NAS:NEOG (USA)
Business Description
Neogen Corp
NAICS : 325412
SIC : 2835
620 Lesher Place, Lansing, MI, USA, 48912
Description
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for global food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.89 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 15.16 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.3 | |||||
| 3-Year EBITDA Growth Rate | -2.3 | |||||
| 3-Year EPS without NRI Growth Rate | -7.6 | |||||
| 3-Year FCF Growth Rate | -4.9 | |||||
| 3-Year Book Growth Rate | 10.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 24.32 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.04 | |||||
| 9-Day RSI | 35.67 | |||||
| 14-Day RSI | 38.65 | |||||
| 6-1 Month Momentum % | -38.44 | |||||
| 12-1 Month Momentum % | -48.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.05 | |||||
| Quick Ratio | 6.48 | |||||
| Cash Ratio | 4.9 | |||||
| Days Inventory | 140.17 | |||||
| Days Sales Outstanding | 64.29 | |||||
| Days Payable | 35.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.1 | |||||
| Operating Margin % | 11.12 | |||||
| Net Margin % | 9.16 | |||||
| ROE % | 5.59 | |||||
| ROA % | 5.04 | |||||
| ROIC % | 9.01 | |||||
| ROC (Joel Greenblatt) % | 21.94 | |||||
| ROCE % | 6.54 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.99 | |||||
| Forward PE Ratio | 18.6 | |||||
| PE Ratio without NRI | 45.99 | |||||
| Shiller PE Ratio | 39.65 | |||||
| Price-to-Owner-Earnings | 47.47 | |||||
| PEG Ratio | 229.95 | |||||
| PS Ratio | 4.23 | |||||
| PB Ratio | 2.49 | |||||
| Price-to-Tangible-Book | 3.54 | |||||
| Price-to-Free-Cash-Flow | 51.1 | |||||
| Price-to-Operating-Cash-Flow | 32.77 | |||||
| EV-to-EBIT | 31.5 | |||||
| EV-to-Forward-EBIT | 11.71 | |||||
| EV-to-EBITDA | 22.44 | |||||
| EV-to-Forward-EBITDA | 9.59 | |||||
| EV-to-Revenue | 3.52 | |||||
| EV-to-Forward-Revenue | 1.81 | |||||
| EV-to-FCF | 43.46 | |||||
| Price-to-Projected-FCF | 1.89 | |||||
| Price-to-Median-PS-Value | 0.58 | |||||
| Price-to-Graham-Number | 2.71 | |||||
| Price-to-Net-Current-Asset-Value | 4.32 | |||||
| Price-to-Net-Cash | 8.17 | |||||
| Earnings Yield (Greenblatt) % | 3.16 | |||||
| Forward Rate of Return (Yacktman) % | 3.07 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:NEOG
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 527.159 | ||
| EPS (TTM) ($) | 0.449 | ||
| Beta | 0.4 | ||
| Volatility % | 29.79 | ||
| 14-Day RSI | 38.65 | ||
| 14-Day ATR ($) | 0.737751 | ||
| 20-Day SMA ($) | 22.043 | ||
| 12-1 Month Momentum % | -48.98 | ||
| 52-Week Range ($) | 20.82 - 47.8 | ||
| Shares Outstanding (Mil) | 107.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Neogen Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||